Early MS shows stronger breathing-linked brain pulsations that may affect how brain fluid moves and relate to symptoms and lesion number.
Researchers used a fast brain scan to look at three types of natural brain pulses that move fluid: heartbeat pulses, slow vessel waves, and breathing pulses. They found that breathing pulses were stronger in fluid spaces around the brain and in many brain areas of people with recent MS, while heartbeat and slow vessel pulses were not different. Stronger breathing pulses were linked with more physical problems, especially in areas that control movement and in a deep brain area called the thalamus (the thalamus is like a relay station that helps send signals around the brain). People with more MS lesions also tended to have stronger breathing pulses, suggesting a connection between these fluid changes and the disease’s damage. Longer time since MS diagnosis was connected to more variation in breathing rate on the brain scans, which could mean breathing-driven flow changes get more uneven over time.
People with MS and their caregivers should care because this study points to a possible way MS affects brain fluid flow that ties to symptoms like weakness or coordination problems. Think of brain fluid moving like water in a garden hose: if the flow pattern changes, some parts may get too much or too little, which could affect nearby brain tissue. Doctors and researchers might use these breathing-related signals to spot early changes or to test treatments that aim to improve fluid flow. This could matter when planning care or therapies because it offers a new target — not just the immune system but also how fluids move around veins. Care teams may eventually monitor these signals to see if a treatment is helping, similar to how blood pressure is checked to assess heart care.
This was a small study with 25 people with early MS who were not on disease-changing drugs, so results may not apply to everyone with MS. The study shows a connection between breathing pulses and MS signs, but it does not prove that the breathing changes cause the damage or symptoms. More research is needed, including larger groups and tests over time, before these findings change current treatments or care routines.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More7/1/2026
Study shows aerobic exercise alters brain circuits linked to automatic body control and fatigue in M
Read More7/1/2026
A simple eye scan and a blood test for sGFAP together help identify people with MS at higher risk of
Read More6/1/2026
Emerging MS therapies aim to slow long-term worsening, target a possible viral trigger, and repair n
Read More5/27/2026
People who later developed MS had different prescription patterns up to 15 years before symptoms—mor
Read More5/27/2026
Study finds a new drug (AcTor) plus ixazomib shuts down cancer cell energy and cleanup systems, high
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.